Could a gentle zap to the spine ease chronic nerve pain?
NCT ID NCT07046143
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a noninvasive electrical stimulation device placed on the skin over the spine can reduce pain and improve quality of life in people with neuropathic (nerve) pain. About 62 adults with chronic low back pain from nerve damage will receive either real or sham stimulation during their hospital stay, then be followed for 3 months. Researchers will measure pain levels, sleep, anxiety, and overall function to see if the treatment helps.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 62 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2025
- Expected to finish
-
Jul 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 18-80 years old; * Meet the diagnostic criteria for neuropathic pain * Chronic low back pain due to neuropathic pain, with or without leg pain; * The skin at the site of irritation is intact; * The patient's vital signs are stable. Exclusion Criteria: * Pain is mainly caused by non-neuropathic factors, such as acute inflammation and trauma; * Those with severe mental illness affecting the study assessment, those with severe cognitive impairment unable to communicate normally or with very poor compliance; * Accompanied by severe cardiac, hepatic, renal and other vital organ insufficiency; * Recently received other related treatments that may affect the impact of neuropathic pain.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Neuropathic pain are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
NanChang
Nanchang, Jiangxi, 330003, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scientists map the daily rhythms of chronic pain
- Can zapping two brain regions at once quiet chronic nerve pain?
- Can a mindfulness app ease the stress of hospitalization?
- Zapping the brain to loosen stiff legs and quiet nerve pain in MS?
- Ancient Mind-Body practice put to the test for spinal cord injury pain
- Can a skin injection of ketamine and lidocaine tame CRPS pain?